Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling
The antiparkinsonian ropinirole and pramipexole are D3 receptor- (D3R-) preferring dopaminergic (DA) agonists used as adjunctive therapeutics for the treatment resistant depression (TRD). While the exact antidepressant mechanism of action remains uncertain, a role for D3R in the restoration of impai...
Saved in:
Main Authors: | Ginetta Collo, Laura Cavalleri, Federica Bono, Cristina Mora, Stefania Fedele, Roberto William Invernizzi, Massimo Gennarelli, Giovanna Piovani, Tilo Kunath, Mark J. Millan, Emilio Merlo Pich, PierFranco Spano |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Neural Plasticity |
Online Access: | http://dx.doi.org/10.1155/2018/4196961 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unchain My Heart: Integrins at the Basis of iPSC Cardiomyocyte Differentiation
by: Rosaria Santoro, et al.
Published: (2019-01-01) -
iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment
by: Jiepu Zong, et al.
Published: (2025-01-01) -
Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models
by: Rubén Fernández-Santiago, et al.
Published: (2016-01-01) -
Multitasking muscle: engineering iPSC-derived myogenic progenitors to do more
by: Mark Stephen Hamer, et al.
Published: (2025-01-01) -
CalciumZero: a toolbox for fluorescence calcium imaging on iPSC derived brain organoids
by: Xiaofu He, et al.
Published: (2025-01-01)